Marta Llanos

1.7k citations
46 papers · 765 indexed · h-index 16
Topics
Lymphoma Diagnosis and Treatment (20 papers)Neuroendocrine Tumor Research Advances (12 papers)Lung Cancer Research Studies (9 papers)

In The Last Decade

Marta Llanos

39 papers receiving 747 citations

Peers

Marta Llanos
Comparison fields: 5 of 69
  • Oncology 445
  • Pathology and Forensic Medicine 275
  • Epidemiology 262
  • Neurology 238
  • Cancer Research 111
Replace Fadi Najjar with:
Fadi Najjar Belgium
Franco Grimaldi Italy
Maria João Bugalho Portugal
Carney Ja United States
İ. Lale Atahan Türkiye
Bogdan Małkowski Poland
A.-F. Cailleux France
Cathérine De Micco France
Edward Limbert Portugal
A Kondi-Pafiti Greece
Marta Llanos relative to Fadi Najjar Belgium Fadi Najjar's profile →
Citations per field
00.5×7.7×
Fadi Najjar · 1×
Citations per year

Countries citing papers authored by Marta Llanos

Since Specialization
Citations

This map shows the geographic impact of Marta Llanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Llanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Llanos more than expected).

Fields of papers citing papers by Marta Llanos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Llanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Llanos. The network helps show where Marta Llanos may publish in the future.

Co-authorship network of co-authors of Marta Llanos

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Llanos. A scholar is included among the top collaborators of Marta Llanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Llanos. Marta Llanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 7
5 30
6 2
7 37
8 1
9 16
10 27
11 45
12 59
13 67
14 15
15 13
16 51
17 7
18 96
19 5
20 25

About Marta Llanos

Marta Llanos is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 46 papers that have together received 765 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Neuroendocrine Tumor Research Advances (12 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Oncology (445 citations), Neurology (238 citations) and Pathology and Forensic Medicine (275 citations). Marta Llanos has collaborated with scholars based in Spain, Palestinian Territory and United States. Frequent co-authors include Norberto Batista, Rocio García‐Carbonero, Josep Tabernero, Vicente Alonso, Emilio González‐Reimers, María Remedios Alemán Valls, Antonio Milena, Juan Luís Gómez-Sirvent, Daniel Castellano and Javier Sastre. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026